当前位置: 首页 >> 检索结果
4701. Travel measures in the SARS-CoV-2 variant era need clear objectives.
作者: Adam J Kucharski.;Mark Jit.;James G Logan.;Matthew Cotten.;Samuel Clifford.;Billy J Quilty.;Timothy W Russell.;Rosanna W Peeling.;Martin Antonio.;David L Heymann.
来源: Lancet. 2022年399卷10333期1367-1369页 4702. Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021.
作者: Luisa S Flor.;Joseph Friedman.;Cory N Spencer.;John Cagney.;Alejandra Arrieta.;Molly E Herbert.;Caroline Stein.;Erin C Mullany.;Julia Hon.;Vedavati Patwardhan.;Ryan M Barber.;James K Collins.;Simon I Hay.;Stephen S Lim.;Rafael Lozano.;Ali H Mokdad.;Christopher J L Murray.;Robert C Reiner.;Reed J D Sorensen.;Annie Haakenstad.;David M Pigott.;Emmanuela Gakidou.
来源: Lancet. 2022年399卷10344期2381-2397页
Gender is emerging as a significant factor in the social, economic, and health effects of COVID-19. However, most existing studies have focused on its direct impact on health. Here, we aimed to explore the indirect effects of COVID-19 on gender disparities globally.
4707. Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial.
作者: Wouter van der Steen.;Rob A van de Graaf.;Vicky Chalos.;Hester F Lingsma.;Pieter Jan van Doormaal.;Jonathan M Coutinho.;Bart J Emmer.;Inger de Ridder.;Wim van Zwam.;H Bart van der Worp.;Irene van der Schaaf.;Rob A R Gons.;Lonneke S F Yo.;Jelis Boiten.;Ido van den Wijngaard.;Jeannette Hofmeijer.;Jasper Martens.;Wouter Schonewille.;Jan Albert Vos.;Anil Man Tuladhar.;Karlijn F de Laat.;Boudewijn van Hasselt.;Michel Remmers.;Douwe Vos.;Anouk Rozeman.;Otto Elgersma.;Maarten Uyttenboogaart.;Reinoud P H Bokkers.;Julia van Tuijl.;Issam Boukrab.;René van den Berg.;Ludo F M Beenen.;Stefan D Roosendaal.;Alida Annechien Postma.;Menno Krietemeijer.;Geert Lycklama.;Frederick J A Meijer.;Sebastiaan Hammer.;Anouk van der Hoorn.;Albert J Yoo.;Dick Gerrits.;Martine T B Truijman.;Sanne Zinkstok.;Peter J Koudstaal.;Sanne Manschot.;Henk Kerkhoff.;Daan Nieboer.;Olvert Berkhemer.;Lennard Wolff.;P Matthijs van der Sluijs.;Henk van Voorst.;Manon Tolhuisen.;Yvo B W E M Roos.;Charles B L M Majoie.;Julie Staals.;Robert J van Oostenbrugge.;Sjoerd F M Jenniskens.;Lukas C van Dijk.;Heleen M den Hertog.;Adriaan C G M van Es.;Aad van der Lugt.;Diederik W J Dippel.;Bob Roozenbeek.; .
来源: Lancet. 2022年399卷10329期1059-1069页
Aspirin and unfractionated heparin are often used during endovascular stroke treatment to improve reperfusion and outcomes. However, the effects and risks of anti-thrombotics for this indication are unknown. We therefore aimed to assess the safety and efficacy of intravenous aspirin, unfractionated heparin, both, or neither started during endovascular treatment in patients with ischaemic stroke.
4710. Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis.
作者: Johannes Schneider-Thoma.;Konstantina Chalkou.;Carola Dörries.;Irene Bighelli.;Anna Ceraso.;Maximilian Huhn.;Spyridon Siafis.;John M Davis.;Andrea Cipriani.;Toshi A Furukawa.;Georgia Salanti.;Stefan Leucht.
来源: Lancet. 2022年399卷10327期824-836页
Schizophrenia is a common, severe, and usually chronic disorder. Maintenance treatment with antipsychotic drugs can prevent relapse but also causes side-effects. We aimed to compare the efficacy and tolerability of antipsychotics as maintenance treatment for non-treatment resistant patients with schizophrenia.
|